James E. Ip
YOU?
Author Swipe
View article: Cardiac implantable electronic device upgrades and downgrades: a <i>Clinical Consensus Statement</i> of the European Heart Rhythm Association (EHRA) of the ESC, the Asia Pacific Heart Rhythm Association (APHRS), Canadian Heart Rhythm Society (CHRS), Heart Rhythm Society (HRS), and the Latin American Heart Rhythm Society (LAHRS)
Cardiac implantable electronic device upgrades and downgrades: a <i>Clinical Consensus Statement</i> of the European Heart Rhythm Association (EHRA) of the ESC, the Asia Pacific Heart Rhythm Association (APHRS), Canadian Heart Rhythm Society (CHRS), Heart Rhythm Society (HRS), and the Latin American Heart Rhythm Society (LAHRS) Open
Cardiac implantable electronic device upgrade and downgrade procedures are increasingly being performed. Whilst the most appropriate guideline-recommended device may have been followed during a patient's initial procedure, the requirements…
View article: Leadless Versus Transvenous Single‐Chamber Ventricular Pacemakers: Real‐World Evidence From Aveir VR Coverage With Evidence Development Study
Leadless Versus Transvenous Single‐Chamber Ventricular Pacemakers: Real‐World Evidence From Aveir VR Coverage With Evidence Development Study Open
Background Aveir VR, a helix‐fixation leadless pacemaker (LP), was US Food and Drug Administration (FDA)‐approved in 2022. The performance of this novel LP has not been evaluated against transvenous single chamber ventricular pacemakers (T…
View article: Differentiating network structures and sex differences of pain-related outcomes, analgesic opioid dosages, and psychosocial factors for postoperative management: a study of PAIN OUT registry in seven Asian regions
Differentiating network structures and sex differences of pain-related outcomes, analgesic opioid dosages, and psychosocial factors for postoperative management: a study of PAIN OUT registry in seven Asian regions Open
Background Despite advancements in global healthcare, Asia lacks a systematic framework for postoperative pain-related symptoms, particularly in addressing pain identification/prevention and reporting sex differences. This study used netwo…
View article: Etripamil Nasal Spray for Recurrent Paroxysmal Supraventricular Tachycardia Conversion: Results From the NODE‐303 Open‐Label Study
Etripamil Nasal Spray for Recurrent Paroxysmal Supraventricular Tachycardia Conversion: Results From the NODE‐303 Open‐Label Study Open
Introduction Etripamil is a fast‐acting intranasally self‐administered calcium‐channel blocker developed for termination of paroxysmal supraventricular tachycardia (PSVT). Prior studies have demonstrated safety and efficacy of etripamil fo…
View article: An Absorbable Antibacterial Envelope Promotes Development of a Healthy Device Pocket: Results of the TYRX Pocket Health Study
An Absorbable Antibacterial Envelope Promotes Development of a Healthy Device Pocket: Results of the TYRX Pocket Health Study Open
Introduction Creation of a pocket and implant of a cardiac implantable electronic device (CIED) elicits a foreign body response in the presence of the normal wound healing process. An absorbable antibacterial envelope (TYRX™, Medtronic Inc…
View article: Battery longevity of a helix-fixation dual-chamber leadless pacemaker: results from the AVEIR DR i2i Study
Battery longevity of a helix-fixation dual-chamber leadless pacemaker: results from the AVEIR DR i2i Study Open
Aims A dual-chamber leadless pacemaker (LP) system that employs distinct atrial and ventricular LP devices (ALP, VLP) has been introduced to clinical practice. Proprietary, low-energy, implant-to-implant (i2i) communication at each beat en…
View article: Intraoperative impedance and electrogram features can predict chronic capture threshold in active fixation ventricular leadless pacemakers
Intraoperative impedance and electrogram features can predict chronic capture threshold in active fixation ventricular leadless pacemakers Open
Background Leadless pacemakers (LP) with the capability to obtain electrical measurements such as impedance and electrograms (EGM) can provide early feedback on implant site selection, before committing to fixation and therefore minimizing…
View article: Self-Administered Etripamil and Emergency Department Visits in Supraventricular Tachycardia
Self-Administered Etripamil and Emergency Department Visits in Supraventricular Tachycardia Open
This secondary analysis of a randomized clinical trial describes the use of emergency care after self-administration of etripamil by patients experiencing paroxysmal supraventricular tachycardia episodes at home.
Dual-chamber leadless pacemaker implant procedural outcomes: Insights from the AVEIR DR i2i study Open
ClinicalTrials.gov identifier: NCT05252702.
Minimizing for Maximum Benefit: An Illustrative Case‐Series of Atrial Only Leadless Pacing Open
Leadless pacing technology now includesdedicated atrial helix‐fixation leadless pacemakers (LPs), expanding theapplication of leadless devices for patients with sinus node dysfunction andatrioventricular block during sinus rhythm. This fir…
Impact of hospital lead extraction volume on management of cardiac implantable electronic device-associated infective endocarditis Open
Aims Utilization of transvenous lead extraction/removal (TLE) for the management of cardiac implantable electronic device (CIED)-associated infective endocarditis (IE) remains low. The aim of this study was to examine the impact of hospita…
Temperature-based rate response in a leadless pacemaker system Open
NCT04559945 (LEADLESS II-Phase 2 study) and NCT05252702 (Aveir DR i2i study).
View article: Patient Preferences for Features Associated With Leadless Versus Conventional Transvenous Cardiac Pacemakers
Patient Preferences for Features Associated With Leadless Versus Conventional Transvenous Cardiac Pacemakers Open
BACKGROUND: Regulatory approval of the first dual-chamber leadless pacemaker system provides patients an alternative to conventional transvenous pacemakers. The study objective was to quantify the preferences of patients for pacemaker feat…
View article: Quality of life measures with etripamil self-administration for acute episodes of paroxysmal supraventricular tachycardia in a medically unsupervised setting: patient-reported outcomes from NODE-303
Quality of life measures with etripamil self-administration for acute episodes of paroxysmal supraventricular tachycardia in a medically unsupervised setting: patient-reported outcomes from NODE-303 Open
Background Etripamil nasal spray (NS) is a fast-acting, self-administered calcium-channel blocker in development for the conversion of AV-nodal dependent paroxysmal supraventricular tachycardia (PSVT) in a medically unsupervised setting. P…
View article: Predictors of Shock‐Reduction Programming and Its Impact on Implantable Cardioverter‐Defibrillator Therapies and Mortality: The CERTITUDE Registry
Predictors of Shock‐Reduction Programming and Its Impact on Implantable Cardioverter‐Defibrillator Therapies and Mortality: The CERTITUDE Registry Open
Background Shock‐reduction implantable cardioverter‐defibrillator programming (SRP) was associated with fewer therapies and improved survival in randomized controlled trials, but real‐world studies investigating SRP and associated outcomes…
Atrioventricular Synchrony Delivered by a Dual-Chamber Leadless Pacemaker System Open
BACKGROUND: A dual-chamber leadless pacemaker system has been designed for atrioventricular synchronous pacing using wireless, beat-to-beat, implant-to-implant (i2i) communication between distinct atrial and ventricular leadless pacemakers…
AV synchrony maintained by a dual-chamber leadless pacemaker in real-world conditions Open
Background/Introduction A dual-chamber leadless pacemaker system has been developed to provide atrial and ventricular pacing and maintain atrioventricular (AV) synchrony. The device demonstrated an ability to maintain consistent AV synchro…
Upgrading a single-chamber leadless pacemaker to a dual-chamber leadless pacemaker system Open
Background/Introduction The first global dual-chamber leadless pacemaker (DR-LP) study included a group of subjects with a pre-existing upgradeable ventricular single chamber leadless pacemaker (VR-LP) in whom the addition of an atrial lea…